Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2025 Earnings Call Transcript August 14, 2025
Brainstorm Cell Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41.
Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded. And I would now like to introduce your host for today’s call, Michael Wood of LifeSci Advisors. Mr. Wood, you...
